Skip to main content

Table 3 Patient characteristics

From: Comparison of conventional and Si-photomultiplier-based PET systems for image quality and diagnostic performance

No.

Tumour type/Indication

Referral category

Age (yr)

Sex

BMI (kg/m2)

Glucose level (mg/dL)

Acc. time Gemini TF (min)

Acc. time Discovery MI (min)

1

Lung cancer

1

70–80

M

26.3

109.8

81

123

2

Malignancy? Vasculitis?

1

60–70

F

24.7

106.2

74

113

3

Pancreatic cancer

2

70–80

F

24.2

108.0

63

102

4

Lung cancer

1

80–90

F

18.4

108.0

63

96

5

Lung cancer

1

70–80

M

28.4

109.8

65

100

6

Malignant melanoma

2

70–80

M

26.6

82.8

64

110

7

Uterus cancer

2

40–50

F

22.4

86.4

59

97

8

Anal cancer

2

40–50

M

25.1

86.4

60

93

9

Pancreatic cancer

2

70–80

F

21.6

122.4

104

61

10

Lung cancer

1

80–90

M

25.9

140.4

118

80

11

Esophageal cancer

1

40–50

M

23.0

113.4

120

76

12

Sarcoidosis

1

40–50

M

26.3

99.0

100

70

13

Uterus cancer

2

70–80

F

17.1

102.6

61

92

14

Lung cancer

1

60–70

F

31.6

100.8

81

62

15

Lung cancer

1

60–70

F

32.7

95.4

79

62

16

Lung cancer

1

60–70

M

23.9

104.4

82

61

  1. *1, initial evaluation/diagnosis/staging; 2, follow-up after treatment. Acc. time accumulation time, BMI body mass index